These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29180385)

  • 41. Low molecular weight heparin versus rivaroxaban in the treatment of venous thromboembolism in gastrointestinal malignancies.
    Choe HK; De Sancho MT; Kim SS; Dai T; Shah MA
    Blood Coagul Fibrinolysis; 2018 Mar; 29(2):227-230. PubMed ID: 29389673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences.
    Samoš M; Bolek T; Ivanková J; Stančiaková L; Kovář F; Galajda P; Kubisz P; Staško J; Mokáň M
    J Cardiovasc Pharmacol; 2016 Nov; 68(5):391-394. PubMed ID: 27464495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST Registry.
    Speed V; Patel JP; Roberts LN; Patel RK; Arya R;
    Thromb Res; 2021 Jan; 197():16-19. PubMed ID: 33160116
    [No Abstract]   [Full Text] [Related]  

  • 44. Epidemiology of the contraceptive pill and venous thromboembolism.
    Hannaford PC
    Thromb Res; 2011 Feb; 127 Suppl 3():S30-4. PubMed ID: 21262435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The economic implications of switching to rivaroxaban from enoxaparin plus vitamin K antagonist in the treatment of venous thromboembolism.
    Patel AA; Ogden K; Mody SH; Bookhart B
    J Med Econ; 2015 May; 18(5):323-32. PubMed ID: 25557176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: Systemic review, traditional meta-analysis, dose-response meta-analysis and network meta-analysis.
    Feng W; Wu K; Liu Z; Kong G; Deng Z; Chen S; Wu Y; Chen M; Liu S; Wang H
    Thromb Res; 2015 Dec; 136(6):1133-44. PubMed ID: 26498222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rivaroxaban program for acute venous thromboembolism upon ED discharge, with focus on utility of commercially available dose pack.
    Chu A; Limberg J
    Am J Emerg Med; 2017 Dec; 35(12):1910-1914. PubMed ID: 28869100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
    Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
    Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state.
    Coleman CI; Turpie AGG; Bunz TJ; Baker WL; Beyer-Westendorf J
    Thromb Res; 2018 Mar; 163():132-137. PubMed ID: 29407625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concomitant Fleischner's lines and reversed halo sign in acute pulmonary embolism: A rare finding.
    Zuin M; Rigatelli G; Roncon L
    Vasc Med; 2019 Dec; 24(6):564-565. PubMed ID: 31303122
    [No Abstract]   [Full Text] [Related]  

  • 51. Progress in the research on venous thromboembolism.
    Zhang Z; Tang L; Hu Y
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):811-815. PubMed ID: 29270736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upper extremity deep venous thrombosis and pulmonary embolus after ovarian hyperstimulation.
    Cramer AC; McLean AW; Ahari J
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27530880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Images in Vascular Medicine: 'Popcorn in the heart': Thromboemboli in transit during acute pulmonary embolism.
    Pradhan A; Sharma R; Vishwakarma P; Sethi R; Narain VS
    Vasc Med; 2018 Aug; 23(4):409-410. PubMed ID: 29600739
    [No Abstract]   [Full Text] [Related]  

  • 54. The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
    Raskob GE; Spyropoulos AC; Zrubek J; Ageno W; Albers G; Elliott CG; Halperin J; Haskell L; Hiatt WR; Maynard GA; Peters G; Spiro T; Steg PG; Suh EY; Weitz JI
    Thromb Haemost; 2016 Jun; 115(6):1240-8. PubMed ID: 26842902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolism.
    Coleman CI; Baugh C; Crivera C; Milentijevic D; Wang SW; Lu L; Nelson WW
    J Med Econ; 2017 Feb; 20(2):200-203. PubMed ID: 27780397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Venous thromboembolism in women taking hormonal contraceptives.
    Blanco-Molina A; Monreal M
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.
    Wells PS; Prins MH; Levitan B; Beyer-Westendorf J; Brighton TA; Bounameaux H; Cohen AT; Davidson BL; Prandoni P; Raskob GE; Yuan Z; Katz EG; Gebel M; Lensing AWA
    Chest; 2016 Nov; 150(5):1059-1068. PubMed ID: 27262225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rivaroxaban for the treatment and prevention of thromboembolic disease.
    Antoniou S
    J Pharm Pharmacol; 2015 Aug; 67(8):1119-32. PubMed ID: 26059702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Questions--answers on the use of rivaroxaban for the treatment of venous thromboembolic disease].
    Pernod G; Elias A; Gouin I; Gaillard C; Nguyen P; Ouvry P; Sié P
    J Mal Vasc; 2012 Dec; 37(6):300-10. PubMed ID: 23122646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral contraception and venous thromboembolism. A New Zealand perspective.
    Roke C
    Drug Saf; 1997 Feb; 16(2):79-87. PubMed ID: 9067120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.